| Name | Title | Contact Details |
|---|
At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.
Corporate Health Systems is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amanna Health Institute is a Alpena, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Las Villas del Norte is a senior living community in Escondido, CA that specializes in independent living, assisted living, and memory care.
MAQUET offers complete medical technology solutions for operating theatres and intensive care units, guaranteeing optimum treatment for patients and greatest-possible working comfort for personnel. MAQUET - The Gold Standard. To enter the MAQUET website